Hinge Health (NYSE:HNGE) Trading 6.3% Higher - Time to Buy?

Key Points

• Earnings beat: Hinge Health reported $0.49 EPS versus $0.04 expected and revenue of $170.7M versus $157.3M, with revenue up 45.5% year‑over‑year.
• Wall Street is broadly positive—the stock has an average rating of "Moderate Buy" with 16 Buy ratings and an average target price of $56.73 (analyst targets up to $68).
• Insider activity and institutional flows: Company insiders sold 442,670 shares (~$18.8M) in the last 90 days despite owning 18.92% of shares, while institutions added positions (e.g., Squarepoint’s ~$19.7M stake).

Hinge Health Inc. (NYSE:HNGE - Get Free Report)'s stock price rose 6.3% during mid-day trading on Monday . The stock traded as high as $48.38 and last traded at $48.2850. Approximately 406,823 shares changed hands during trading, a decline of 63% from the average daily volume of 1,107,332 shares. The stock had previously closed at $45.43.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on HNGE shares. Stifel Nicolaus set a $59.00 price objective on shares of Hinge Health in a research note on Thursday, February 5th. KeyCorp set a $55.00 price target on shares of Hinge Health in a report on Wednesday, February 11th. Needham & Company LLC reiterated a "buy" rating and issued a $59.00 price target on shares of Hinge Health in a research report on Wednesday, February 11th. Piper Sandler dropped their price objective on shares of Hinge Health from $71.00 to $60.00 and set an "overweight" rating for the company in a research note on Friday, January 9th. Finally, Wells Fargo & Company started coverage on Hinge Health in a research note on Thursday, January 8th. They issued an "overweight" rating and a $68.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $56.73.

Hinge Health Trading Up 7.7%

The stock has a market cap of $3.85 billion and a price-to-earnings ratio of -3.82. The firm's 50 day moving average is $42.03 and its two-hundred day moving average is $43.94.

Hinge Health (NYSE:HNGE - Get Free Report) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.45. The firm had revenue of $170.73 million for the quarter, compared to analysts' expectations of $157.31 million. The company's revenue was up 45.5% compared to the same quarter last year. As a group, equities analysts expect that Hinge Health Inc. will post 0.78 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Chairman Gabriel M.I. Mecklenburg sold 33,333 shares of the firm's stock in a transaction on Tuesday, April 21st. The stock was sold at an average price of $45.05, for a total transaction of $1,501,651.65. Following the sale, the chairman owned 33,333 shares in the company, valued at $1,501,651.65. This trade represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Antonio Perez sold 166,665 shares of the company's stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $40.26, for a total value of $6,709,932.90. The disclosure for this sale is available in the SEC filing. Insiders have sold 442,670 shares of company stock worth $18,786,901 over the last ninety days. Company insiders own 18.92% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Marshall Wace LLP purchased a new stake in Hinge Health in the second quarter valued at approximately $367,000. Sei Investments Co. purchased a new position in Hinge Health during the second quarter worth approximately $869,000. Squarepoint Ops LLC acquired a new position in shares of Hinge Health in the 2nd quarter valued at $19,706,000. Raymond James Financial Inc. purchased a new stake in shares of Hinge Health during the 2nd quarter valued at $3,258,000. Finally, Sandia Investment Management LP purchased a new stake in shares of Hinge Health during the 2nd quarter valued at $657,000.

Hinge Health Company Profile

Hinge Health NYSE: HNGE is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.